Agree, this is a major step forward with serious partners. Long term share holders potentially can wait for substantial growth with top quality products targeting large markets. I can offer a past experience review to maybe help with longer perspective for EVE. Five years ago, I invested in A2Milk Co when they first listed @ 50 cents. Their share price today is over $12, after being as high as $17. The first 2 years was a slow increase. My long experienced broker had asked at the initial purchase, "Is this company fair dinkum?" Being a dairy farmer with lifetime knowledge of quality milk products, and having previously met some of the founders of A2m in Australia, I said YES, it is a genuine product with a difference! Then a legal challenge on the product's integrity was mounted by a mega company, 6 months after listing. I sold some shares. The legal challenge disappeared, and the share price kept climbing after the enormous Chinese and other markets are successfully tapped. Check their 5 year growth graph. It shows the value of a unique and genuinely healthy product, compared to lesser rivals, and how all long term investors with clear knowledge of the real health benefits of their company's well researched and developed product range can reap the rewards for their commitment. Eve has top quality products, and is fast approaching Chinese and other major market opportunities. About 2 years time will give us a better picture of market and income potential. Customer recognition and acceptance takes time. We must apply some patience with confidence in the managerial plans for a robust future. E B.
EVE Price at posting:
0.6¢ Sentiment: Buy Disclosure: Held
(20min delay)